MACULAR EDEMA SECONDARY TO INFLAMMATION
Clinical trials for MACULAR EDEMA SECONDARY TO INFLAMMATION explained in plain language.
Never miss a new study
Get alerted when new MACULAR EDEMA SECONDARY TO INFLAMMATION trials appear
Sign up with your email to follow new studies for MACULAR EDEMA SECONDARY TO INFLAMMATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New eye injection aims to control dangerous swelling
Disease control Recruiting nowThis study is testing if a new eye injection called tabirafusp alfa (KSI-101) can safely reduce swelling in the retina caused by inflammation. It will involve about 150 people with this specific type of eye swelling and compare the real injection to a sham (pretend) procedure. Th…
Matched conditions: MACULAR EDEMA SECONDARY TO INFLAMMATION
Phase: PHASE3 • Sponsor: Kodiak Sciences Inc • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New eye injection aims to halt vision loss from inflammation
Disease control Recruiting nowThis study is testing if an experimental drug called KSI-101, injected into the eye, can safely reduce swelling and improve vision in people with macular edema caused by inflammation. It will compare the drug against a sham (pretend) injection in 150 participants. The main goal i…
Matched conditions: MACULAR EDEMA SECONDARY TO INFLAMMATION
Phase: PHASE3 • Sponsor: Kodiak Sciences Inc • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC